Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SQLE | Q14534 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL466592 | 1.00 | GPR84 (0.43) | GPR84FFAR1FFAR4LMNAALDH1A1 | |
| SCHEMBL466721 | 1.00 | GPR84 (0.43) | GPR84FFAR1FFAR4LMNAALDH1A1 | |
| SCHEMBL466548 | 1.00 | — | — | |
| SCHEMBL466959 | 1.00 | GPR84 (0.43) | GPR84FFAR1FFAR4LMNAALDH1A1 | |
| SCHEMBL466782 | 0.97 | — | — | |
| SCHEMBL466793 | 0.88 | — | — | |
| SCHEMBL27605472 | 0.87 | TDP1 (0.41) | GPR84FFAR1FFAR4LMNAALDH1A1 | |
| SCHEMBL8466765 | 0.87 | TDP1 (0.41) | GPR84FFAR1FFAR4LMNAALDH1A1 | |
| SCHEMBL25978438 | 0.87 | TDP1 (0.41) | GPR84FFAR1FFAR4LMNAALDH1A1 | |
| SCHEMBL4797472 | 0.87 | TDP1 (0.41) | GPR84FFAR1FFAR4LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2850050-B1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2018-12-12 | — | — | EP | disclosed |
| US-9193651-B2 | Process for the chemoselective reduction of terminally saturated carboxylic esters | GIVAUDAN S.A. (CH) | 2015-11-24 | — | — | US | disclosed |
| US-9193651-B2 | Process for the chemoselective reduction of terminally saturated carboxylic esters | GIVAUDAN S.A. (CH) | 2015-11-24 | — | — | US | disclosed |
| US-9193651-B2 | Process for the chemoselective reduction of terminally saturated carboxylic esters | GIVAUDAN S.A. (CH) | 2015-11-24 | — | — | US | disclosed |
| US-20150152029-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2015-06-04 | — | — | US | disclosed |
| US-20150152029-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2015-06-04 | — | — | US | disclosed |
| US-20150152029-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2015-06-04 | — | — | US | disclosed |
| EP-2850050-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | Givaudan SA (CH) | 2015-03-25 | — | — | EP | disclosed |
| US-8877857-B2 | Polar group-containing copolymer, rubber composition and studless tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2014-11-04 | — | — | US | disclosed |
| EP-2404944-B1 | POLAR GROUP-CONTAINING COPOLYMER, RUBBER COMPOSITION AND STUDLESS TIRE | SUMITOMO RUBBER IND (JP) | 2014-05-14 | — | — | EP | disclosed |
| WO-2013171302-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | GIVAUDAN SA (CH) | 2013-11-21 | — | — | WO | disclosed |
| WO-2012060387-A1 | NOVEL DIHYDROXYBENZENE DERIVATIVES AND ANTIPROTOZOAL AGENT COMPRISING SAME AS ACTIVE INGREDIENT | アリジェン製薬株式会社 (JP) | 2012-05-10 | — | — | WO | disclosed |
| US-20120095153-A1 | POLAR GROUP-CONTAINING COPOLYMER, RUBBER COMPOSITION AND STUDLESS TIRE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-2404944-A1 | POLAR GROUP-CONTAINING COPOLYMER, RUBBER COMPOSITION AND STUDLESS TIRE | Sumitomo Rubber Industries, Ltd. (JP) | 2012-01-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152029-A1 | PROCESS FOR THE CHEMOSELECTIVE REDUCTION OF TERMINALLY SATURATED CARBOXYLIC ESTERS | ADH5, ADH1A, ADH1C | GPR84 2067/4885FFAR1 136/4885FFAR4 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.